![](/img/cover-not-exists.png)
Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from 60 Prospectively Treated Patients
Doles, Jason D., Hogan, Kelly A., O'Connor, Jennifer, Wahner Hendrickson, Andrea E., Huston, Olivia, Jatoi, AminahLanguage:
english
Journal:
Journal of Palliative Medicine
DOI:
10.1089/jpm.2018.0023
Date:
May, 2018
File:
PDF, 177 KB
english, 2018